Bausch & Lomb Corp Financing Cash Flow
Bausch & Lomb Corp (BLCO) reported Financing Cash Flow of $14.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-29
- Bausch & Lomb Corp net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $34.00M, a 62.22% decline year-over-year.
- Bausch & Lomb Corp net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$20.00M, a 164.52% decline year-over-year.
- Bausch & Lomb Corp net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $116.00M, a 20.55% decline year-over-year.
- Bausch & Lomb Corp net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$12.00M.
- Bausch & Lomb Corp net cash provided by (used in) financing activities for fiscal 2025 was $225.00M, a 26.40% increase from fiscal 2024.
- Bausch & Lomb Corp net cash provided by (used in) financing activities for fiscal 2024 was $178.00M, a 91.43% decline from fiscal 2023.
- Bausch & Lomb Corp net cash provided by (used in) financing activities for fiscal 2023 was $2.08B, a 2465.43% increase from fiscal 2022.
- Bausch & Lomb Corp net cash provided by (used in) financing activities for fiscal 2022 was $81.00M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $34.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $14.00M 10-Q · filed 2026-07-29 | $130.00M derived: sum of 3 quarters · filed 2026-07-29 | $118.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$20.00M 10-Q · filed 2026-04-29 | $96.00M derived: sum of 2 quarters · filed 2026-04-29 | $84.00M derived: sum of 3 quarters · filed 2026-04-29 | $174.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $116.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $104.00M derived: sum of 2 quarters · filed 2026-02-18 | $194.00M derived: sum of 3 quarters · filed 2026-07-29 | $225.00M 10-K · filed 2026-02-18 |
| 2025-09-30 | -$12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $78.00M derived: sum of 2 quarters · filed 2026-07-29 | $109.00M 10-Q · filed 2025-10-29 | $255.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $90.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $121.00M 10-Q · filed 2026-07-29 | $267.00M derived: sum of 3 quarters · filed 2026-07-29 | $247.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $31.00M 10-Q · filed 2026-04-29 | $177.00M derived: sum of 2 quarters · filed 2026-04-29 | $157.00M derived: sum of 3 quarters · filed 2026-04-29 | $197.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $146.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $126.00M derived: sum of 2 quarters · filed 2026-02-18 | $166.00M derived: sum of 3 quarters · filed 2026-02-18 | $178.00M 10-K · filed 2026-02-18 |
| 2024-09-30 | -$20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $20.00M derived: sum of 2 quarters · filed 2025-10-29 | $32.00M 10-Q · filed 2025-10-29 | $118.00M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $40.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $52.00M 10-Q · filed 2025-07-30 | $138.00M derived: sum of 3 quarters · filed 2026-02-18 | $1.95B derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $12.00M 10-Q · filed 2025-04-30 | $98.00M derived: sum of 2 quarters · filed 2026-02-18 | $1.91B derived: sum of 3 quarters · filed 2026-02-18 | $2.00B derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $86.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.90B derived: sum of 2 quarters · filed 2026-02-18 | $1.99B derived: sum of 3 quarters · filed 2026-02-18 | $2.08B 10-K · filed 2026-02-18 |
| 2023-09-30 | $1.81B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $1.90B derived: sum of 2 quarters · filed 2024-10-30 | $1.99B 10-Q · filed 2024-10-30 | $1.99B derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $90.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $181.00M 10-Q · filed 2024-08-01 | $174.00M derived: sum of 3 quarters · filed 2025-02-19 | $65.00M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $91.00M 10-Q · filed 2024-05-01 | $84.00M derived: sum of 2 quarters · filed 2025-02-19 | -$25.00M derived: sum of 3 quarters · filed 2025-02-19 | $120.00M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$116.00M derived: sum of 2 quarters · filed 2025-02-19 | $29.00M derived: sum of 3 quarters · filed 2025-02-19 | $81.00M 10-K · filed 2025-02-19 |
| 2022-09-30 | -$109.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $36.00M derived: sum of 2 quarters · filed 2023-11-01 | $88.00M 10-Q · filed 2023-11-01 | $51.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $145.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $197.00M 10-Q · filed 2023-08-02 | $160.00M derived: sum of 3 quarters · filed 2024-02-21 | -$218.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $52.00M 10-Q · filed 2023-05-03 | $15.00M derived: sum of 2 quarters · filed 2024-02-21 | -$363.00M derived: sum of 3 quarters · filed 2024-02-21 | -$546.00M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | -$37.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$415.00M derived: sum of 2 quarters · filed 2024-02-21 | -$598.00M derived: sum of 3 quarters · filed 2024-02-21 | -$712.00M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$378.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$561.00M derived: sum of 2 quarters · filed 2022-11-02 | -$675.00M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | -$183.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$297.00M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$114.00M 10-Q · filed 2022-06-08 | |||
| 2020-12-31 | -$232.00M 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B |